LLY

1,071.32

+0.71%↑

JNJ

208.42

+0.07%↑

ABBV

226.26

+0.83%↑

UNH

333.8

+2.13%↑

AZN

91.77

+1.24%↑

LLY

1,071.32

+0.71%↑

JNJ

208.42

+0.07%↑

ABBV

226.26

+0.83%↑

UNH

333.8

+2.13%↑

AZN

91.77

+1.24%↑

LLY

1,071.32

+0.71%↑

JNJ

208.42

+0.07%↑

ABBV

226.26

+0.83%↑

UNH

333.8

+2.13%↑

AZN

91.77

+1.24%↑

LLY

1,071.32

+0.71%↑

JNJ

208.42

+0.07%↑

ABBV

226.26

+0.83%↑

UNH

333.8

+2.13%↑

AZN

91.77

+1.24%↑

LLY

1,071.32

+0.71%↑

JNJ

208.42

+0.07%↑

ABBV

226.26

+0.83%↑

UNH

333.8

+2.13%↑

AZN

91.77

+1.24%↑

Search

Moleculin Biotech Inc

Ouvert

3.78 -7.35

Résumé

Variation du prix de l'action

24h

Actuel

Min

3.71

Max

4.11

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+396.08% upside

Moleculin Biotech Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

18 déc. 2025, 23:54 UTC

Actions en Tendance

Stocks to Watch: Nike, Cassava Sciences, KB Home

18 déc. 2025, 23:51 UTC

Résultats

Nike Sales Tick Up in 2Q; China Weakness Persists -- Update

18 déc. 2025, 23:39 UTC

Principaux Mouvements du Marché

Cassava Sciences Shares Fall After FDA Places Hold on Epilepsy Drug Trial

18 déc. 2025, 22:57 UTC

Acquisitions, Fusions, Rachats

TikTok Signs Agreement for Sale of U.S. Unit, Axios Reports, Citing a Memo

18 déc. 2025, 21:40 UTC

Résultats

Nike Sales Tick Up, But China Weakness Persists

18 déc. 2025, 23:45 UTC

Market Talk

Gold Steady, Supported by Fed Rate-Cut Prospects -- Market Talk

18 déc. 2025, 23:37 UTC

Market Talk
Résultats

Nike 2Q Results Fail to Convince Investors of Recovery -- Market Talk

18 déc. 2025, 23:36 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Rally -- Market Talk

18 déc. 2025, 23:03 UTC

Acquisitions, Fusions, Rachats

Mitsubishi Materials: Impact on Consolidated Results for FY Ending March 2026 Likely to be Immaterial

18 déc. 2025, 23:02 UTC

Acquisitions, Fusions, Rachats

Mitsubishi Materials: To Acquire 4,448 Common Shares, 13,771 Preferred Shares of Co.

18 déc. 2025, 23:00 UTC

Acquisitions, Fusions, Rachats

Mitsubishi Materials: Investment to Strengthen Recovery Network in U.S.

18 déc. 2025, 22:59 UTC

Acquisitions, Fusions, Rachats

Mitsubishi Materials: Investment to Contribute to Expanding Collection Volume of Secondary Raw Material

18 déc. 2025, 22:58 UTC

Acquisitions, Fusions, Rachats

SpaceX Could Go Public by Merging With EchoStar. It Isn't a Crazy Idea. -- Barrons.com

18 déc. 2025, 22:57 UTC

Acquisitions, Fusions, Rachats

Mitsubishi Materials: Elemental USA E-Waste Operates E-Waste Recycling Business in U.S.

18 déc. 2025, 22:56 UTC

Acquisitions, Fusions, Rachats

Mitsubishi Materials: To Acquire Portion of Shares of Elemental USA E-Waste & ITAD

18 déc. 2025, 22:55 UTC

Résultats

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 déc. 2025, 21:59 UTC

Résultats

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 déc. 2025, 21:50 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

18 déc. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18 déc. 2025, 21:35 UTC

Résultats

FedEx's Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

18 déc. 2025, 21:31 UTC

Résultats

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q Europe, Middle East & Africa Rev $3.39B >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q Greater China Rev Down 17% >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q EPS 53c >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q Apparel Rev $3.91B >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q Equipment Rev $550M >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q N Amer Rev $5.63B >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q Footwear Rev $7.66B >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q Asia Pacific & Latin America Rev Down 4% >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q Greater China Rev $1.42B >NKE

Comparaison

Variation de prix

Moleculin Biotech Inc prévision

Objectif de Prix

By TipRanks

396.08% hausse

Prévisions sur 12 Mois

Moyen 19 USD  396.08%

Haut 31 USD

Bas 4 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

3 ratings

3

Achat

0

Maintien

0

Vente

Éléments financiers

$

help-icon Live chat